{"prompt": "['24', 'much time each subject is expected to be involved in the study (e.g., The', 'involvement of each subject will be 1-session for a total of 90 minutes).', 'A) The project is funded in the form a cost-reimbursement contract for which a', 'specific milestone schedule exists. The contract start date is 9/15/16 and the', 'contract term date is 7/14/20. All analyses will be completed by the term date.', 'Details are available in the attached milestone schedule.', 'B) Therapist subjects will be involved for 6 months in phase 1, as well as through the', 'phase 2 trial (approximately 2 years, though with variability depending on when', 'they have been assigned and have treated their 6 study cases). Patient subjects in', 'phase 1 only will be involved in the study protocol through their actual termination', 'point or 16 weeks, whichever comes sooner. Patients in phase 2 only will be', 'involved in the study protocol through their actual termination point or 16', 'weeks, whichever comes sooner (we will also conduct a follow-up outcome', 'assessment at 1 year after termination on a randomly-selected subsample of 40', 'patients).', '5. Risks', 'HHS Regulations define a subject at risk as follows: any individual who may be exposed to', 'the possibility of injury, including physical, psychological, or social injury, as a consequence of', \"participation as a subject in any research. 'This also includes risks to subject confidentiality\", 'and any discomforts, hazards, or inconveniences.', 'For the categories below, include a description of risks.', 'a. Describe the risks related to:', 'Physical well-being', 'None anticipated.', 'Psychological well-being', 'Regardless of condition, all participating clinics will employ their usual triage', 'assessments, therapists will employ their usual treatments, and patients will be', 'receiving their usual treatments. Consequently, there are no risks from our research', 'protocol over and above what would normally be expected in routine assessment', 'and psychotherapy, and the clinics all have their clinical and safety protocols in place', '(and clinical personnel to execute them).', 'In treatment, some individuals may experience emotional upset during sessions.', 'Additionally, some participants may experience disappointment with their rate of', 'progress or setbacks. The risk associated with such reactions will be addressed', 'clinically by the therapists who are treating these issues and who have peer and', 'administrative support. To reiterate, these treatment risks would occur in the course', 'of treatment-as-usual These are not additional risks stemming from the research']['25', 'protocol. Further, outcome monitoring systems, which the basis of our protocol, are', 'already being used by Atrius providers without incident.', 'As is typical in psychological research, some of the assessment questions from the', 'research measures may be experienced as intrusive and/or may cause anxiety. The', 'risk from such increased anxiety, however, is minimized by the use of skilled and', 'extensively trained assessors who are aware that such reactions may be related to a', \"person's presenting problems, or simply a function of the intimate and emotionally\", 'intense nature of psychological services. In addition, the Pls, PC, and Atrius site staff', 'and administrators will be available to meet with any participant who may be unduly', 'disturbed due to the few research tasks. Because the pre- and posttreatment', 'diagnostic interviews will be conducted via telephone, the graduate RA (being', 'trained as a clinician and supervised by their site PI, Dr. Constantino or Boswell, both', 'of whom are licensed clinical psychologists and mental health care providers) will', \"have the patient's contact information (phone number and current address) on\", 'hand. If the patient reveals clinically elevated suicidality or homicidality, the RA will', \"contact 9-1-1 and report the patient's contact information and location address for\", 'emergency response. The RA, if applicable, will also execute any duty to warn to the', 'best of their ability (in addition to contacting the local authorities).', 'There is also the possibility that the research team will become aware of critical', 'items being endorsed on the TOP (e.g., suicidal ideation). In this case, the PI or PC', '(who will be responsible for regularly reviewing TOP data as it is collected) will', 'inform the Atrius Co-PI (Dr. Nordberg), who will determine if the therapist should be', 'notified of these critical item responses. However, as Atrius therapists will', 'constantly be engaging in psychological and risk assessments as part of routine care,', 'this information will likely be known already. To be sure, though, Atrius will have a', 'protocol in place to share critical item data without having to share the full TOP', 'report (which, as per the research design, is not being shared with clinicians).', 'Economic well-being', 'Given that therapist performance data are being collected, it is reasonable to be', 'concerned about possible employment implications were an employer (i.e., clinic', 'administrator) to attempt to interpret study information incompletely (i.e., infer lack', 'of therapist effectiveness to the point of questioning employability). This risk,', 'however, is extremely minimal for the following reasons:', '(1) As a condition of being involved in the study, clinic administrators will be', \"required to agree that therapists' participation or non-participation in this research\", 'will in no way affect their standing/employment at their community mental health', 'clinic.', '(2) The research team will not reveal therapist performance data to clinic', 'administrators or staff members; that is, the study could be considered \"triple-']\n\n###\n\n", "completion": "END"}